Clinical Trial Update: Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating gene signatures to guide therapy for HR-positive metastatic breast cancer in a diverse cohort; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Cancer

Snippet

Sponsor: Sonya Reid | Conditions: Invasive Mammary Carcinoma, Metastatic Breast Cancer | Phase 2 | Status: RECRUITING